Sage Therapeutics Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects

Sage Therapeutics Inc’s stock has seen a rocky market performance. The company’s stock achieved a 1-year high of $13.47 on 07/23/24, and the lowest price during that time was $4.62, recorded on 11/20/24.

52-week price history of SAGE Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Sage Therapeutics Inc’s current trading price is -32.96% away from its 52-week high, while its distance from the 52-week low is 95.45%. The stock’s price range for this period has remained between $4.62 and $13.47. The Healthcare sector company’s shares managed to surpass a trading volume of around 19.06 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.97 million over the last three months.

Financial Performance and Market Capitalization

Sage Therapeutics Inc (SAGE) has experienced a quarterly rise of 12.59% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 565.47M and boasts a workforce of 353 employees.

Moving average and trading volume data

SAGE Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SAGE stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.02.

SAGE Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant gain of 66.30% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 53.31%. Over the past 30 days, the price of SAGE has fallen by 36.61%. And in the last five days, it has surged by 32.60%.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.